Filing Flows › QuidelOrtho (QDEL) › R&D spending
QuidelOrtho (QDEL) R&D spending by quarter
QuidelOrtho's R&D spending was $42.5M in Q3 2026 (third quarter 2026), -13% from Q2 2026. Over the last 7 quarters it ranged from $41.5M (Q3 2025) to $53.2M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $42.5M | -13% | +2% |
| Q2 2026 | $48.7M | +8% | +7% |
| Q1 2026 | $44.9M | -2% | -16% |
| Q4 2025 | $45.8M | +10% | — |
| Q3 2025 | $41.5M | -9% | — |
| Q2 2025 | $45.7M | -14% | — |
| Q1 2025 | $53.2M | — | — |
Q3 2026 at a glance
QuidelOrtho, Q3 2026: revenue $619M (-12% year over year), operating margin -1.2%, net loss $53.8M, operating cash flow $19.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is QuidelOrtho's R&D spending?
QuidelOrtho's R&D spending was $42.5M in Q3 2026 (third quarter 2026), -13% from Q2 2026.
How has QuidelOrtho's R&D spending changed?
Over the last 7 quarters it ranged from $41.5M (Q3 2025) to $53.2M (Q1 2025).